LS-C98443

antibody from LSBio

Targeting: FDFT1 SQS

Antibody data

Submit

Validation data

Product number: LS-C98443 - Provider product page
Provider: LSBio
Proper citation: LifeSpan Cat#LS-C98443, RRID:AB_2104739
Product name: FDFT1 / Squalene Synthase Antibody (aa140-170) LS-C98443
Antibody type: Polyclonal
Description: Ammonium sulfate precipitation
Reactivity: Human
Host: Rabbit
Storage: Maintain refrigerated at 2°C to 8°C for up to 6 months. For long term storage store at -20°C.

FDFT1 protein structure - LS-C98443 shown in red.

Enhanced validation

Submitted by: LSBio (provider)
Enhanced method: Genetic validation
Main image
Experimental details: Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma.

Supportive validation

Submitted by: LSBio (provider)
Enhanced method: Genetic validation
Main image
Experimental details: Formalin-fixed and paraffin-embedded human hepatocarcinoma tissue reacted with FDFT1 Antibody , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.

Supportive validation

Submitted by: LSBio (provider)
Main image
Experimental details: Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma.

Supportive validation

Submitted by: LSBio (provider)
Main image
Experimental details: Formalin-fixed and paraffin-embedded human hepatocarcinoma tissue reacted with FDFT1 Antibody , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.